Evidence map›Paper›PMID 8825942›Full record

ArticleBiochemical genetics1995

Expression of carbonic anhydrase II (CA II) promoter-reporter fusion genes in multiple tissues of transgenic mice does not replicate normal patterns of expression indicating complexity of CA II regulation in vivo.

R P Erickson, J Grimes, P J Venta, R E Tashian

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

R P EricksonDepartment of Pediatrics, University of Arizona, Tucson, USA.
J Grimes
P J Venta
R E Tashian
University of Michigan–Ann Arbor · USChildren's Center · USUniversity of Arizona · US

Funding

NATIONAL TRANSGENIC MOUSE FACILITYN01HD002911 · NICHD · DNX, INC. · PI SWANSON, MARK · 1990 to 1995
–
MOLECULAR GENETICS OF THE CARBONIC ANHYDRASESR01GM024681 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TASHIAN, RICHARD E · 1985 to 1997
–
MANIPULATING MAMMALIAN DEVELOPMENT WITH ANTISENSE RNAR01HD026454 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ERICKSON, ROBERT P · 1990 to 1992
–
NICHD NIH HHS HD26454NICHD NIH HHS N01-HD-0-2911NIGMS NIH HHS GM24681
6 · The paper itself

Abstract

Although the proximal, 5' 115 bp of the human carbonic anhydrase II (CA II) gene was sufficient for expression of a reporter gene in some transfected cell lines, we found previously that 1100 bp of this promoter (or 500 bp of the mouse CA II promoter) was not sufficient for expression in transgenic mice. We have now studied the expression of linked reporter genes in mice transgenic for either (1) 11 kb of the human 5' promoter or (2) 8 kb of the human 5' promoter with mouse sequences from the first exon, part of the first intron (since a CpG island spans this region), and the 3' sequences of the gene. Expression was found in both cases, but the tissue specificity was not appropriate for CA II. Although there was a difference in the sensitivity of the assays used, the first construct led to expression in many tissues, while the second construct was expressed only in spleen. These findings indicate considerable complexity of DNA control regions for in vivo CA II expression.

Indexed as

AnimalsBase SequenceCarbonic AnhydrasesDNA PrimersGene Expression Regulation, EnzymologicGenes, ReporterHumansMiceMice, TransgenicMolecular Sequence DataPromoter Regions, GeneticRecombinant Fusion ProteinsCarbonic AnhydrasesDNA PrimersRecombinant Fusion Proteins

Identifiers

PMID8825942
OpenAlexW2113138769

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.